Related Experiment Videos
New cerebral protection strategies
Serge C Thal1, Kristin Engelhard, Christian Werner
1Department of Anesthesiology, Johannes Gutenberg University, Mainz, Germany.
Current Opinion in Anaesthesiology
|March 15, 2006
Summary
Effective secondary brain injury management focuses on controlling physiological factors like temperature and blood glucose. While no single drug offers complete neuroprotection, interventions like osmodiuretics and magnesium show promise for specific conditions.
Area of Science:
- Neuroscience
- Critical Care Medicine
- Neurology
Background:
- Secondary brain damage results from complex pathophysiology following initial neuronal injury.
- Single pharmacological interventions are unlikely to provide sustained neuroprotection due to the intricate nature of cerebral ischemia.
Purpose of the Study:
- To review current and significant strategies for mitigating secondary brain damage.
- To highlight the importance of managing acute physiological derangements after brain injury.
Main Methods:
- Analysis of clinical studies on neuroprotection and secondary brain injury.
- Review of experimental and clinical data on various therapeutic interventions.
Main Results:
- Acute physiological derangements (fever, hypertension/hypotension, hypoxemia, hypercapnia, hyperglycemia) are key predictors of poor outcomes.
- Osmodiuretics are effective in reducing intracranial pressure; magnesium may prevent vasospasm after subarachnoid hemorrhage.
- Anesthetic agents show neuroprotective potential in vitro but lack proven human benefit; prophylactic glucocorticoids should be avoided.
Conclusions:
- Management of physiological variables, including temperature and glucose control, is crucial.
- Anesthetic agents and osmodiuretics aid in controlling intracranial hypertension.
- Prophylactic magnesium and statins may benefit specific patient groups to reduce neuronal injury and stroke risk.